Shire Human Genetic Therapies, Inc. recalls Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only,

Recalled October 2, 2019 · FDA recall D-0038-2020 · Shire Human Genetic Therapies

Hazard

Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing · FDA Class I

Units

8,003

Sold at

Product was distributed throughout the United States.

Description

Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing

Product

Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA 68875-0205-02

Manufacturer(s)

Shire Human Genetic Therapies, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →